Choose GELSYN-3 for proven outcomes9

GELSYN-3 has efficacy equivalent to a high-molecular-weight hyaluronic acid comparator:

  • A 3-injection series of GELSYN-3 (0.8% highly purified, hyaluronic acid of biofermentation origin) or Synvisc® (0.8% hylan G-F 20)
  • Patients (N=380) were observed for a period of 26 weeks
  • Primary outcome measure: WOMAC pain score at 26 weeks

Synvisc is a registered trademark of Genzyme Biosurgery.

Pain Reduction Tolerability Percentage

 

GELSYN-3 also demonstrated improvements in knee function, stiffness, and global pain scores.

2.1-middlesection-iStock-1081493552

GELSYN-3 performed as well as Synvisc in terms of effectiveness and safety, providing patients with long-lasting, clinically relevant pain relief.9

See GELSYN-3 Safety Information

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.